COMPOSITION Water (Aqua), Dipropylene Glycol, Glycerin, Niacinamide, Glutathione, Arbutin, Ascorbic Acid, Ascorbyl Diphosphate 3Na, Ascorbyl Phosphate Mg, Tetrahexyldecyl Ascorbate, Palmitoyl Ascorbate, Glycyrrhizic Acid 2K, Butylene Glycol, Tripropylene Glycol, Hydrogenated Lecithin, Soy Sterol, Ceramide NP, Phellodendron Amurense Bark Extract, Lavender Oil, Lemon Peel Oil, Lime Oil, Lemongrass Oil, Juniperus Communis (Pencil Cedar) Oil, Rosemary Leaf Oil, PEG-60 Hydrogenated Castor Oil, Xanthan Gum, Ethylhexylglycerin, Potassium Hydroxide, Citric Acid, Sodium Citrate, Etidronic Acid, Linoleic Acid, Linolenic Acid, Lecithin
PPARgama activation-mediated egr-1 inhibition benefits against brain injury in an experimental ischaemic stroke model
Research Peptides in Australia Interest in research peptides across Australia continues growing as laboratories and researchers explore advanced peptide compounds and signaling pathways
The decreased expression and signaling of TLRs, essential for recognizing pathogen-associated molecular patterns (PAMPs), further impair the ability of aging macrophages to phagocyte apoptotic cells and respond to pathogens
